TrialBMC cancer2026

Peripheral monocyte ratio as a predictive biomarker for metastasis-directed therapy in prostate cancer: insights from an exploratory study.

Hanzhi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.